KOCAA
GMAB icon

Knights of Columbus Asset Advisors’s Genmab GMAB Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,732
Closed -$214K – 382
2023
Q4 		$214K Buy
6,732
+1,020
+18% +$32K 0.01% 311
2023
Q3 		$201K Buy
5,712
+822
+17% +$31.3K 0.02% 313
2023
Q2 		$186K Buy
4,890
+1,385
+40% +$55.2K 0.02% 320
2023
Q1 		$132K Buy
3,505
+79
+2% +$3.04K 0.01% 319
2022
Q4 		$145K Buy
+3,426
New +$141K 0.02% 307

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Knights of Columbus Asset Advisors's GMAB Position: Q1 2024 in Review

Knights of Columbus Asset Advisors sold out of Genmab (GMAB) in Q1 2024, closing a stake of 6,732 shares — an estimated $214K sold.

Knights of Columbus Asset Advisors first reported a position in GMAB in Q4 2022 and held it in 5 quarters. The position peaked at $214K in Q4 2023. 228 funds tracked by Wall St. Rank hold GMAB as of Q1 2024.

  • Knights of Columbus Asset Advisors reported no remaining Genmab position as of Q1 2024 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 6,732 Genmab shares in Q1 2024, an estimated $214K.
  • Knights of Columbus Asset Advisors first reported a position in Genmab in Q4 2022 and held it in 5 quarters.
  • Knights of Columbus Asset Advisors's Genmab position peaked at $214K in Q4 2023.
  • 228 funds tracked by Wall St. Rank held Genmab as of Q1 2024.

Based on Knights of Columbus Asset Advisors's 13F filing for Q1 2024, filed 10 May 2024.